ADVERUM BIOTECHNOLOGIES INC's ticker is and the CUSIP is 00773U908. A total of 3 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,400 | +38139.0% | 121,600 | +40433.3% | 0.00% | – |
| Q2 2023 | $477 | -99.9% | 300 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $386,440 | -47.1% | 666,900 | -13.4% | 0.00% | 0.0% |
| Q3 2022 | $731,000 | -27.6% | 769,800 | -8.5% | 0.00% | -50.0% |
| Q2 2022 | $1,009,000 | -13.8% | 841,000 | -5.9% | 0.00% | +100.0% |
| Q1 2022 | $1,171,000 | -53.6% | 893,900 | -37.7% | 0.00% | -50.0% |
| Q4 2021 | $2,525,000 | -11.6% | 1,434,400 | +8.9% | 0.00% | -33.3% |
| Q3 2021 | $2,857,000 | +282.0% | 1,316,600 | +515.8% | 0.00% | +200.0% |
| Q2 2021 | $748,000 | +236.9% | 213,800 | +850.2% | 0.00% | – |
| Q1 2021 | $222,000 | -56.4% | 22,500 | -52.1% | 0.00% | -100.0% |
| Q4 2020 | $509,000 | +243.9% | 47,000 | +226.4% | 0.00% | – |
| Q3 2020 | $148,000 | -62.1% | 14,400 | -23.0% | 0.00% | -100.0% |
| Q2 2020 | $390,000 | +207.1% | 18,700 | +43.8% | 0.00% | +100.0% |
| Q1 2020 | $127,000 | -49.6% | 13,000 | -40.6% | 0.00% | -50.0% |
| Q4 2019 | $252,000 | -18.2% | 21,900 | -61.3% | 0.00% | 0.0% |
| Q3 2019 | $308,000 | +3750.0% | 56,600 | +7985.7% | 0.00% | – |
| Q2 2019 | $8,000 | -95.7% | 700 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $187,000 | +196.8% | 35,600 | +78.0% | 0.00% | +100.0% |
| Q4 2018 | $63,000 | -86.8% | 20,000 | -74.7% | 0.00% | -75.0% |
| Q3 2018 | $477,000 | +21.7% | 78,900 | +6.6% | 0.00% | +33.3% |
| Q2 2018 | $392,000 | -48.6% | 74,000 | -43.7% | 0.00% | -62.5% |
| Q1 2018 | $762,000 | – | 131,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 26,100 | $3 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |